Adaptin Bio (APTN) Accounts Payables (2022 - 2026)

Adaptin Bio has disclosed Accounts Payables across 5 years of filings, most recently posting $1.4 million for Q1 2026.

• Quarterly Accounts Payables rose 319.29% year-over-year to $1.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.4 million (up 319.29% YoY) and the FY2025 annual result came in at $1.5 million, up 11.09% from the prior year.
• Accounts Payables fell to $1.4 million in Q1 2026, from $1.5 million in the prior quarter.
• Across five years, Accounts Payables topped out at $1.5 million in Q4 2025 and bottomed at $58.0 in Q4 2023.
• The 5-year median for Accounts Payables is $190091.5 (2024), against an average of $564688.8.
• Year-over-year, Accounts Payables sank 99.54% in 2023 and surged 2346591.38% in 2024.
• Adaptin Bio's Accounts Payables stood at $12500.0 in 2022, then sank by 99.54% to $58.0 in 2023, then surged by 2346591.38% to $1.4 million in 2024, then advanced by 11.09% to $1.5 million in 2025, then decreased by 9.31% to $1.4 million in 2026.
• According to Business Quant data, Accounts Payables over the past three periods registered $1.4 million, $1.5 million, and $1.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.